Target intelligence / Profile preview

Energy expenditure pathway mRNA

Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Energy expenditure pathway mRNA refers to a collective group of messenger RNA molecules that encode proteins essential for the regulation of metabolic rate and thermogenesis. Key examples include the mRNA for Uncoupling Protein 1 (UCP1), which mediates non-shivering thermogenesis in brown adipose tissue, and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis and oxidative metabolism (Source: NIH, PubMed). These transcripts are fundamental to maintaining energy homeostasis, and their dysregulation is a hallmark of metabolic disorders such as obesity and type 2 diabetes (Source: Nature Reviews Endocrinology). While most current clinical interventions target the proteins within these pathways, there is significant research into using RNA-based therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), to directly modulate the expression of these metabolic regulators (Source: Molecular Therapy). The therapeutic goal is often to increase the activity of energy-dissipating pathways to combat weight gain and insulin resistance, though achieving tissue specificity remains a primary challenge (Source: Cell Metabolism).

Other names
Metabolic pathway transcriptsThermogenic mRNAsEnergy homeostasis mRNAsEnergy expenditure gene set
02

Mechanism of action

Modulation of protein expression levels through the targeted degradation, stabilization, or replacement of messenger RNA transcripts involved in metabolic rate and heat production.

03

Biological functions

Energy homeostasisThermogenesisMitochondrial biogenesisMetabolic regulationLipid metabolism
04

Disease associations

ObesityType 2 diabetesMetabolic syndromeCachexia
05

Safety considerations

Off-target RNA interferencePotential for systemic hyperthermiaTissue-specific delivery challengesLiver and kidney toxicity associated with oligonucleotide delivery systems
06

Interacting drugs

Experimental antisense oligonucleotides

2 more in the full profile.

07

Biomarkers

UCP1 mRNA expression levelsPPARGC1A (PGC-1alpha) expression levelsResting metabolic rate (RMR)Oxygen consumption rate (OCR)

Beyond the preview

Go deeper on Energy expenditure pathway mRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energy expenditure pathway mRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call